Test Directory

Test Code
1667
Test Name
Stuve-Wiedemann Syndrome
CPT Codes
81479
Expected Turnaround Time
Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited.
Clinical Utility
Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members.
Specimen and Container Info

Non-Prenatal Specimens

Preferred/Alternate

Specimen Type

Containers

Volume

Preferred Specimen Type

Whole Blood

Lavender Top (EDTA)

3 mL

Alternate Specimen Type

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

Alternate Specimen Type

Fibroblasts

T-25 Flasks

2 confluent T-25 flasks, filled to capacity

Alternate Specimen Type

Saliva (Whole blood is recommended for CNV)

DNA Self-Collection Kit or Oragene Saliva Collection Kit for Young Children

Follow kit instructions (www.dnagenotek.com)

Prenatal Specimens

Either specimen type below is acceptable.

Specimen Type

Containers

Volume

Cultured cells

T-25 Flasks

2 confluent T-25 flasks derived from amnio or CVS samples.

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico.

Transport Instructions
  • Transport at room temperature within 24 hours.
  • If the specimen cannot be transported to the lab within 24 hours, refrigerate for up to 72 hours.
  • Do not freeze or expose to extreme temperatures, refrigerate for up to 72 hours if cannot be transported to lab within 24 hours. 
Stability Requirements

Room Temperature

24 hours

Refrigerated

72 hours

Causes for Rejection
  • Improperly labeled specimen (minimum of two patient identifiers)
  • Inappropriate specimen type
  • Incomplete or incorrect test request form
  • Insufficient volume
  • Specimen has leaked in transit
  • Specimen without a test order
Methodology
Next Generation Sequencing and Copy Number Variation Analysis
Performing Location
Genomics - Snowdrift
Alternate Names
STWS
Description

Stuve-Wiedemann syndrome (STWS; MIM 601559) is an autosomal recessive, frequently lethal disorder characterized by postnatal short stature, congenital bowing of the long bones and dysautonomia. The bones of the lower extremities are usually more affected than the bones of the upper extremities. The long bones display cortical thickening and an abnormal trabecular pattern. The metaphyses are wide, flared, rarefied and striated. Talipes valgus and contractures of the elbows, knees, fingers and toes have also been described. Infants typically have an expressionless face with pursed lips. Poor feeding, respiratory insufficiency and temperature instability in the form of episodic hyperthermia often lead to death in the first year of life. Survivors have progressive scoliosis due to severe spinal deformities, prominent joints, osteoporosis, and spontaneous fractures. Sucking and swallowing difficulties improve over time however temperature instability (hyper and hypothermia), and decreased corneal and patellar reflexes persist. Although STWS appears to display genetic heterogeneity, mutations in the leukemia inhibitory factor receptor gene (LIFR) have been identified in many patients. This gene encodes one of two components of the LIF receptor. This receptor binds multiple cytokines including leukemia inhibitory factor and induces signaling through the JAK/STAT and MAPK pathways.

Testing Schedule
Monday-Friday
Genes
LIFR
MIM
601559
Disease Group
Skeletal Disorders